Back

Live panel discussion.

27 August 2021 (13:30 - 13:45)
Organised by:
Congress Presentation Part of: Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists Risk Factors and Prevention Open Access ESC Congress 2021 - The Digital Experience

3 More presentations in this session

Presentation thumbnail
Glucagon-like peptide 1 receptor agonists & cardiovascular outcomes: What have we learned?
Associate Professor M. Cavender (Chapel Hill, US)
Video
Presentation thumbnail
Cardiovascular effects of glucagon-like peptide 1 receptor agonists.
Doctor M. Husain (Toronto, CA)
Video
Presentation thumbnail
Glucagon-like peptide 1 receptor agonist use in cardiology.
Professor M. Petrie (Glasgow, GB)
Video

Access the full session

Session thumbnail
Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 13:30 CET
You may be interested in
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources